Clinical Trial Update: Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study [NA]

View source ↗

Summary

Open-label feasibility trial assessing perineural incobotulinumtoxinA for Complex Regional Pain Syndrome (types I and II) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type
• Complex Regional Pain Syndrome Type Ii

Drugs mentioned

• Xeomin (incobotulinumtoxinA) (incobotulinumtoxinA)

Snippet

Sponsor: Bo Biering-Soerensen | Conditions: CRPS (Complex Regional Pain Syndromes), CRPS (Complex Regional Pain Syndrome) Type I | NA | Status: RECRUITING